4D pharma PLC Sponsored ADR LBPS

Market cap
$37.2M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '21 Feb '21 Dec '20 Feb '20 Dec '19 Feb '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 — 0.00 — —
P/S ratio
697.71 0.00 0.00 0.00 0.00 — 0.00 — —
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 — 0.00 — —
P/Operating CF
(51.89) (6.69) (6.29) (24.94) (24.21) — (68.73) — —
P/B ratio
31.35 4.63 4.36 138.85 21.88 — 3.54 — —
Price to Tangible BV
76.45 9.40 8.87 0.00 55.76 — 0.00 — —
EV/Sales
692.37 0.00 0.00 0.00 0.00 — 0.00 — —
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 — 0.00 — —
EV/Operating CF
(10.96) (3.13) (3.57) (12.28) (14.97) — 0.00 — —
EV/FCF
(10.81) (3.03) (3.57) (12.28) (14.97) — 0.00 — —
Quick Ratio
4.56 1.97 1.97 1.09 1.86 13.07 154.46 10.90 14.60
Current Ratio
5.21 2.45 2.45 2.28 2.28 14.38 14.38 11.60 15.19
Net Debt/EBITDA
0.23 0.33 0.33 (0.03) 0.10 1.45 1.41 2.58 5.52
Debt/Assets
21.59% 0.00% 2.22% 3.01% 3.01% 0.00% 0.05% 0.00% 0.00%
Debt/Equity
0.39 0.03 0.03 0.04 0.04 0.00 0.00 0.00 0.00
Asset Turnover
0.02 0.03 0.02 0.01 0.01 0.00 0.01 0.00 0.00
Operating CF/Net income
1.19 0.89 0.89 0.94 0.95 1.19 20.28 0.82 1.29
Capex/Depreciation
(0.19) (0.13) (0.15) (0.38) (0.43) — 0.00 0.00 0.00
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(89.48%) (78.27%) (87.26%) (97.93%) (167.65%) (7.67%) (0.03%) (27.48%) (12.11%)
ROA
(108.64%) (124.24%) (67.82%) (74.49%) (74.02%) (0.93%) (0.07%) (48.05%) (11.07%)
ROIC
(96.48%) (77.94%) (77.94%) (77.69%) (91.89%) (6.30%) (6.27%) 0.00% 0.00%
Return on Tangible Assets
(100.26%) (175.12%) (175.09%) (218.91%) (218.35%) (58.60%) (0.21%) (35.23%) (13.35%)
Average Days of Receivables
4,695.69 2,538.60 2,538.60 9,564.63 9,564.63 — 9,381.59 0.00 0.00
Research and Development Expense of Revenue
3,012.81% 3,388.99% 3,388.99% 10,852.42% 10,852.42% — 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
2,212.81% 1,886.23% 1,886.23% 3,858.74% 3,858.74% — 163.42% 0.00% 0.00%
Intangible Assets out of Total Assets
0.33 0.00 0.40 0.46 0.46 0.00 0.00 0.00 0.15
Share Based Compensation of Revenue
99.03% 47.97% 47.97% 126.39% 126.39% — 0.00% — —
Graham Net Nets
0.01 0.06 0.06 (0.05) 0.01 — (2.00) — —
Graham Number
0.00 0.00 0.00 0.00 0.00 — 0.00 — —
Earnings Yield
(12.34%) (3.74%) (3.97%) (5.00%) (6.41%) — (3.64%) — —
Free Cash Flow Yield
(9.18%) (31.01%) (26.23%) (8.16%) (6.64%) — 0.00% — —
Revenue per Share
0.03 0.00 0.05 0.00 0.00 0.00 0.03 0.00 0.00
Operating CF per Share
(1.79) 0.00 (1.91) 0.00 (0.44) (0.30) (0.04) (0.35) (0.24)
Capex per Share
(0.01) 0.00 (0.02) 0.00 (0.01) 0.00 0.00 0.00 0.00
Free Cash Flow per Share
(1.80) 0.00 (1.93) 0.00 (0.45) (0.30) (0.04) (0.35) (0.24)
Cash per Share
0.99 0.00 0.84 0.00 0.08 0.42 0.08 1.04 1.31
Shareholders Equity per Share
1.53 0.00 2.73 0.00 0.48 3.28 0.61 1.45 1.65
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
1.53 0.00 2.73 0.00 0.48 3.28 0.61 1.45 1.65
Free Cash Flow
(38.19) (27.48) (27.50) (29.31) (29.38) (0.45) (0.29) (22.54) (15.74)
Working Capital
27.88 12.34 12.34 8.30 8.30 0.65 0.65 71.37 86.47
Capital Expenditures
(0.28) (0.21) (0.23) (0.63) (0.70) — 0.00 (2.81) (2.86)
Net Current Asset Value
8.12 10.72 10.72 5.15 5.15 (35.43) (35.43) 67.36 84.32
EV/EBIT
0.00 0.00 0.00 0.00 0.00 — 0.00 — —
Capex to Sales
0.39 0.31 0.33 2.33 2.60 — 0.00 — —
Net Profit Margin
(4,448.19%) (4,420.43%) (4,419.57%) (11,305.20%) (11,276.21%) 0.00% (5.32%) 0.00% 0.00%
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 — 0.00 — —
Other line items
Depreciation/Fixed assets
0.37 0.31 0.31 0.29 0.29 — 0.00 0.19 0.16
Cash ROIC
(63.39%) (62.15%) (62.15%) (105.66%) (91.54%) (8.07%) (115.36%) (18.27%) (10.70%)
Accounts Receivable Turnover
0.10 0.14 0.12 0.04 0.04 — 0.04 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.69 0.39
Inventory Turnover
0.00 — 0.00 — 0.00 — 0.00 4.17 2.40
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 670.16 686.89
Days of Inventory on Hand
0.00 — 0.00 — 0.00 — 88.13 94.04 140.57
Average Receivables
7.02 4.80 5.92 7.05 6.98 — 6.37 4.96 4.96
Average Payables
3.11 4.54 3.09 1.64 0.84 0.03 1.23 1.94 1.94
Average Inventory
0.38 — 0.33 — 0.32 — 0.36 0.32 0.32
Average Assets
29.40 24.55 44.96 40.83 40.98 41.13 20.56 57.50 110.03
Average Common Equity
35.69 38.97 34.95 31.05 18.09 5.00 49.65 100.54 100.54

Fold the line items

Columns are period end dates